Double-blind, placebo-controlled trial of daunorubicin and cytarabine with or without recombinant human granulocyte colony-stimulating factor in elderly patients with acute myeloid leukemia: economic evaluation with attention to inpatient and outpatient resource utilization

Autor:	D A, Freund, R S, Dittus
Rok vydání:	1995
Předmět:	Leukemia Myeloid Acute Double-Blind Method Cost-Benefit Analysis Daunorubicin Granulocyte Colony-Stimulating Factor Outpatients Cytarabine Humans Antineoplastic Agents Middle Aged Recombinant Proteins Aged Randomized Controlled Trials as Topic
Zdroj:	Journal of the National Cancer Institute. Monographs. (19)
ISSN:	1052-6773
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=pmid________::79f072b6d8f01b5c8786cc3d82a32768 https://pubmed.ncbi.nlm.nih.gov/7577203 Zobrazit plný text záznamu